These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 10475711)

  • 1. Animal models of Alzheimer's disease.
    Higgins LS
    Mol Med Today; 1999 Jun; 5(6):274-6. PubMed ID: 10475711
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological transgenic mouse models of Alzheimer's disease.
    Crews L; Rockenstein E; Masliah E
    Handb Clin Neurol; 2008; 89():291-301. PubMed ID: 18631753
    [No Abstract]   [Full Text] [Related]  

  • 3. Alzheimer's research moves to mice.
    Marx J
    Science; 1991 Jul; 253(5017):266-7. PubMed ID: 1907022
    [No Abstract]   [Full Text] [Related]  

  • 4. Transgenic mouse models of Alzheimer's disease.
    Janus C; Chishti MA; Westaway D
    Biochim Biophys Acta; 2000 Jul; 1502(1):63-75. PubMed ID: 10899432
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular and molecular biology of Alzheimer's disease and animal models.
    Price DL; Sisodia SS
    Annu Rev Med; 1994; 45():435-46. PubMed ID: 8198393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic animal models for Alzheimer's disease.
    Fukuchi K; Ogburn CE; Smith AC; Kunkel DD; Furlong CE; Deeb SS; Nochlin D; Sumi SM; Martin GM
    Ann N Y Acad Sci; 1993 Sep; 695():217-23. PubMed ID: 8239285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New 'Alzheimer's mouse' produced.
    Marx J
    Science; 1996 Oct; 274(5285):177-8. PubMed ID: 8927978
    [No Abstract]   [Full Text] [Related]  

  • 8. Reduced β-amyloid pathology in an APP transgenic mouse model of Alzheimer's disease lacking functional B and T cells.
    Späni C; Suter T; Derungs R; Ferretti MT; Welt T; Wirth F; Gericke C; Nitsch RM; Kulic L
    Acta Neuropathol Commun; 2015 Nov; 3():71. PubMed ID: 26558367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of amyloid beta-protein in Alzheimer's disease.
    Regland B; Gottfries CG
    Lancet; 1992 Aug; 340(8817):467-9. PubMed ID: 1354793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mouse models of Alzheimer's disease.
    Sirinathsinghji DJ
    Biochem Soc Trans; 1998 Aug; 26(3):504-8. PubMed ID: 9765905
    [No Abstract]   [Full Text] [Related]  

  • 11. Critical thinking of Alzheimer's transgenic mouse model: current research and future perspective.
    Li X; Quan M; Wei Y; Wang W; Xu L; Wang Q; Jia J
    Sci China Life Sci; 2023 Dec; 66(12):2711-2754. PubMed ID: 37480469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview on rodent models of Alzheimer's disease.
    Dodart JC; May P
    Curr Protoc Neurosci; 2005 Nov; Chapter 9():Unit 9.22. PubMed ID: 18428631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Images in neuroscience. Alzheimer's disease: from genes to pathogenesis.
    Selkoe DJ
    Am J Psychiatry; 1997 Sep; 154(9):1198. PubMed ID: 9286176
    [No Abstract]   [Full Text] [Related]  

  • 14. [Alzheimer's disease. Molecular pathology, animal models, and current treatment].
    Bayer TA; Wirths O
    Nervenarzt; 2008 Nov; 79 Suppl 3():117-25; quiz 126-7. PubMed ID: 18820894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of amyloid beta protein precursor processing as a means of retarding progression of Alzheimer's disease.
    Wagner SL; Munoz B
    J Clin Invest; 1999 Nov; 104(10):1329-32. PubMed ID: 10562291
    [No Abstract]   [Full Text] [Related]  

  • 16. Progress toward valid transgenic mouse models for Alzheimer's disease.
    Guénette SY; Tanzi RE
    Neurobiol Aging; 1999; 20(2):201-11. PubMed ID: 10537029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease: molecular genetics and transgenic animal models.
    Lannfelt L; Folkesson R; Mohammed AH; Winblad B; Hellgren D; Duff K; Hardy J
    Behav Brain Res; 1993 Nov; 57(2):207-13. PubMed ID: 8117426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background.
    Irizarry MC; Rebeck GW; Cheung B; Bales K; Paul SM; Holzman D; Hyman BT
    Ann N Y Acad Sci; 2000; 920():171-8. PubMed ID: 11193147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
    Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
    Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.